## Implementation

- [x] 1. Define local contracts and versioned context with verified public source metadata.
- [x] 2. Write failing positive/negative/unknown and fail-closed regression tests.
- [x] 3. Implement pure deterministic evaluation and synthetic A–E fixture expectations.
- [x] 4. Document the demo story and architecture boundary; review spec, TypeScript and clinical-safety conformance inline.
- [x] 5. Run focused tests, pnpm verify, e2e, format and strict OpenSpec validation; record actual evidence.

## Evidence (Oct 22, 2026)

- RED: focused Vitest against the fail-closed evaluator stub: 31 failed, 7 passed (38). Failures included expected READY_FOR_REVIEW versus BLOCKED and unknown/exclusion boundaries.
- GREEN: `pnpm exec vitest run src/server/clinical-rules/evaluate.test.ts`: 38 passed. No domain behavior mocked; only the server-only marker is mocked for Node tests.
- `pnpm verify`: exit 0; 6 tooling tests, lint, strict typecheck, 163 Vitest tests across 3 files and production build passed.
- `pnpm test:e2e`: exit 0; `22 passed (3.4m)` on desktop/mobile Chromium. Sandboxed teardown stalled after every test passed; only the verified test server from this run was terminated to complete teardown. No other worker server was stopped.
- `pnpm format:check`: exit 0; all matched files use Prettier style.
- `pnpm exec openspec validate --all --strict --no-interactive`: 4 passed, 0 failed before archival.
- Inline self-review applied spec-conformance, clinical-safety, general code and TypeScript reviewer guidance: bounded context, unknown handling, evidence references, provenance, server-only imports and review requirements checked. No TSX or authorization/publication code changed. No independent reviewer claimed; native AO review follows PR creation.
- Source verification and automated retrieval limits are recorded in DEMO_SCENARIOS.md. Formal medical review and full persisted A–E journeys are not verified by this task.

After archival, update only P0-05 with its archive and PR links, rebase on origin/main, open the authorized PR and request native AO review. Never merge.
